NASDAQ · Medical - Devices

CTKB (CTKB) Stock

$4.38 -1.79% NASDAQ: CTKB Healthcare

Valuation

MetricValue
Price$4.38
Market Cap$565.64M
P/E Ratio-7.25
P/B Ratio1.42
P/S Ratio2.51
EPS (TTM)$0.00
52-Week High$6.18
52-Week Low$2.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-19.59%
ROA-14.50%
ROCE-11.70%
Gross Margin-20.40%
Operating Margin-19.90%
Net Margin-36.25%
Debt/Equity0.11
Current Ratio5.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$128.0M$164.0M$193.0M$200.0M$201.0M
Operating Profit$9.0M$-2.0M$-28.0M$-21.0M$-40.0M
Net Profit$3.0M$3.0M$-12.0M$-6.0M$-67.0M
EPS$0.03$0.02$-0.09$-0.05$-0.52
Op Margin7.2%-1.1%-14.4%-10.2%-20.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$463.0M$519.0M$494.0M$500.0M$462.0M
Total Liabilities$58.0M$94.0M$101.0M$104.0M$120.0M
Cash$365.0M$297.0M$167.0M$99.0M$91.0M
Borrowings$0$18.0M$14.0M$17.0M$24.0M

Latest News

Cytek Biosciences Opens Innovation Center in Washington MT Newswires · Jul 15, 2026 Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement GlobeNewswire · Jul 15, 2026 Cytek Biosciences Removes Chief Legal Officer MT Newswires · Jun 26, 2026 Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets Simply Wall St. · Jun 17, 2026 Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference GlobeNewswire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$5.0M$-12.0M$5.0M$25.0M$-5.0M
Investing Cash Flow$-25.0M$-66.0M$-99.0M$-86.0M$6.0M
Financing Cash Flow$1.0M$3.0M$-41.0M$-19.0M$-16.0M
Net Cash Flow$198.0M$-65.0M$-132.0M$-69.0M$-8.0M
Free Cash Flow$0$-22.0M$0$22.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.47%
Quick Ratio4.07
Interest Coverage—
Return 1Y35.31%
Return 3Y-50.43%
Return 5Y—

Ownership

Insiders Held8.42%
Institutions Held67.59%
Institutions Float Held73.80%
Institutional HolderSharesReport Date
Blackrock Inc.17,007,2692026-03-31
Topline Capital Management, LLC7,064,4812026-03-31
HHLR Advisors, LTD6,657,0302026-03-31
Millennium Management Llc6,291,7982026-03-31
Boston Partners5,802,7732026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANGO $14.63 +2.02% -14.36 $604.69M 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
CBLL $18.81 +3.07% -11.62 $713.70M 0.00%
CLPT $14.14 -2.68% -13.09 $424.05M 0.00%
KIDS $22.77 -0.26% -10.79 $584.85M 0.00%

About CTKB

CTKB is led by CEO Wenbin Jiang, publicly traded since 2021.

CTKB stock trades at $4.38 with a market capitalization of $565.64M. The stock is valued at a price-to-earnings (P/E) ratio of -7.25, price-to-book of 1.42, price-to-sales of 2.51. Over the past 52 weeks the stock has ranged between $2.90 and $6.18, and currently trades 29.1% below its 52-week high.

On profitability, CTKB generates a return on equity (ROE) of -19.59%, return on capital employed of -11.70%, an operating margin of -19.90%, a net profit margin of -36.25%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides